SB273005 structure
|
Common Name | SB273005 | ||
---|---|---|---|---|
CAS Number | 205678-31-5 | Molecular Weight | 451.44 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 662.9±55.0 °C at 760 mmHg | |
Molecular Formula | C22H24F3N3O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 354.7±31.5 °C |
Use of SB273005SB-273005 is a potent nonpeptide and orally active integrin antagonist with Kis of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively[1]. |
Name | HG7MY8V9AA |
---|---|
Synonym | More Synonyms |
Description | SB-273005 is a potent nonpeptide and orally active integrin antagonist with Kis of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 662.9±55.0 °C at 760 mmHg |
Molecular Formula | C22H24F3N3O4 |
Molecular Weight | 451.44 |
Flash Point | 354.7±31.5 °C |
Exact Mass | 451.171906 |
LogP | 3.16 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.563 |
Storage condition | -20℃ |
[(4S)-8-{2-[6-(Methylamino)-2-pyridinyl]ethoxy}-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl]acetic acid |
1H-2-Benzazepine-4-acetic acid, 2,3,4,5-tetrahydro-8-[2-[6-(methylamino)-2-pyridinyl]ethoxy]-3-oxo-2-(2,2,2-trifluoroethyl)-, (4S)- |
[(4S)-8-{2-[6-(methylamino)pyridin-2-yl]ethoxy}-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl]acetic acid |
HG7MY8V9AA |
SB273005 |